Cumulative Digestive Damage • LI Staging
Segmental Evaluation
The Lémann Index requires detailed cross-sectional imaging (MRE/CTE) and pan-endoscopy to quantify structural lesions (strictures, fistulae, perianal ulcers). Utilize specialized LI software or scoring sheets for the full multi-segmental composite score.
Guidelines & Evidence
Verified
Last Review: 2026
When to Use
When to Use
Objective quantification of cumulative bowel damage in Crohn's disease (CD)
Measuring disease progression independent of current clinical symptoms (HBI/CDAI)
Evaluating the efficacy of "Treat-to-target" strategies in preventing long-term structural morbidity
Used primarily in clinical research and specialized IBD academic centers
Damage vs. Activity
The Lémann index measures irreversible structural changes (strictures, fistulas, resections), whereas the CDAI or HBI measures reversible inflammatory "activity." A patient can be in clinical remission but have a high Lémann Index.
How it Works
The 4 Anatomical Segments
01
Upper GI (Oesophagus, Stomach, Duodenum).
02
Small Bowel (Jejunum, Ileum).
03
Colon and Rectum.
04
Anus (Perianal disease).
Assessment Modalities
Calculation typically requires cross-sectional imaging (MRE or CTE) along with colonoscopy results and surgical history.
Scoring Logic
| Grade 0 | No damage |
| Grade 1 | Stricture without dilation |
| Grade 2 | Stricture with dilation OR Simple fistula |
| Grade 3 | Complex fistula OR Resection |
Clinical Pearls
Preventing the "Disabled" Patient
The Lémann index is the first tool to acknowledge that Crohn's is a progressive, destructive disease. By tracking the index over years, a "Damage Slope" can be calculated. A steep slope indicates a patient who needs highly aggressive biological therapy to prevent imminent intestinal failure.
The Surgical Connection
Previous surgical resections contribute heavily to the Lémann index. This acknowledges that while surgery solves an immediate problem (e.g., obstruction), it represents a permanent loss of bowel "capital."
Clinical Pearls
Lémann Score > 7.0 at diagnosis is a strong predictor of early surgical requirement
Unlike the CDAI, the Lémann Index almost never decreases; the goal of therapy is "Damage Stabilization"
MRI Enterography (MRE) is the preferred imaging modality for calculating the small bowel component
Next Steps
Longitudinal Management
01
Rising Lémann Index: Failure of current strategy. Escalate biologicals or consider early surgical optimization.
02
Stable Lémann Index: "Deep Remission" achieved. Continue successful maintenance.
The Evidence
The Foundational Index
Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.
Pariente B et al. • Gastroenterology. 2015;148(1):52-63. The primary description of the index.
View Source• . ;
Validation Study
Validation of the Lémann index to assess cumulative digestive damage in Crohn’s disease.
Fiorino G et al. • Aliment Pharmacol Ther.. 2015;42(11):1271-8. Confirming the index's robustness.
View SourceOrigins & History
Marcel Lémann
Named in honour of Professor Marcel Lémann, a Parisian gastroenterologist who dedicated his career to understanding the structural progression of Crohn's. The index was developed by an international working group (the "Lémann Task Force") to provide a "Damage" counterpart to the many "Activity" scores in existence.
Last Comprehensive Review: 2026